Asahi Kasei Corporation

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care. On October 1, 2003, all core operations were transferred to seven wholly owned constituent corporations as autonomous operating business units. Asahi Kasei Corporation, as the parent company, functions as a holding company for group operations. An Independent Businesses Group not included in the constituent corporations provides group services

Contact Details: 535 Madison Avenue, 33rd Floor New York New York 10022 United States of America Tel: 1-212-371-9900 Fax: 1-212-371-9050 Email: extech@om.asahi-kasei.co.jp WWW: www.asahi-kasei.co.jp/

Loading...

Recent Publications by Asahi Kasei Corporation:
Identification of biofoulant of membrane bioreactors in soluble microbial products. To reveal primary biofoulant in soluble microbial products (SMP) and/or...	17th November, 2009	Microza & Water Processing Division, Asahi Kasei Chemicals Co., Ltd.,	Water Res. 2009 Sep;43(17):4356-62. Epub 2009 Jun 25. DOI Direct Link
Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage. We investigated the neuroprotective effects of fasudil's active...	3rd September, 2009	Research Center, Asahi Kasei Pharma Corporation 632-1, Mifuku,	Brain Res Bull. 2009 Aug 31. DOI Direct Link
Discovery of selective PDE4B inhibitors. In this study the first PDE4B selective inhibitor is described....	22nd August, 2009	Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1	Bioorg Med Chem Lett. 2009 Jun 15;19(12):3174-6. Epub 2009 May 3. DOI Direct Link
Collaborative work on evaluation of ovarian toxicity. 13) Two- or four-week repeated dose studies and fertility study of PPAR alpha/gamma dual agonist in female rats. The main focus of this study was to determine the optimal dosing period in...	1st July, 2009	Laboratory for Safety Assessment & ADME, Pharmaceuticals Research Center,	J Toxicol Sci. 2009;34 Suppl 1:SP137-46.
Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat. 1. The study aimed to investigate the pharmacokinetics of thrombomodulin...	25th June, 2009	Pharmaceuticals Research Center, Asahikasei Pharma Co., Shizuoka, Japan.	Xenobiotica. 2009 Feb;39(2):125-34. DOI Direct Link
→View more Asahi Kasei Corporation research publications.

Press Releases on Asahi Kasei Corporation:
Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review	23rd November, 2009	Reportlinker	NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Medical Nonwoven Disposables - A Worldwide Market Review http://www
NxStage Announces Strategic Business Alliance with Asahi Kasei Kuraray Medical	18th May, 2009	NxStage Medical, Inc.	- Alliance Establishes Partnership with Leading Renal Products Company in Asia - Collaboration Expected to Yield Gross Margin Improvement and Accelerate Path to Profitability - Financing Provided

BioNews Results for Asahi Kasei Corporation:
Viral reduction method for plasma using a leukocyte-reduction filter and two virus-reduction filters of decrea	PharmCast:  Oct 9 2009 12:02PM Matching: asahi kasei
Reportlinker Adds Small Molecule Kinase Inhibitors Report	PR Newswire via Yahoo!:  Sep 8 2009 2:27PM Matching: asahi kasei
Asahi Kasei Starts Operation At New Integrated Research Complex	Pharmaceutical Business Review:  Sep 2 2009 12:44AM Matching: asahi kasei

Asahi Kasei Corporation Clinical Trials:
A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Asahi Kasei Corporation Patents:
US Patent No.	Title
7501474	Polyphenylene ether resin composition
7540980	Conductive resin composition and molded object
7541399	Process for producing polyphenylene ether resin composition
7541482	Process for production of alkyltin alkoxides
7544379	Composite containing fine cellulose
→View more Asahi Kasei Corporation patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 21 individuals from Asahi Kasei Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 571 times since April 2007, the link to the organisation's website has been followed 60 times

Recent Search Terms used to find this page: company profile pdf jp | Asahi Kasei Chemicals Corporation mail | Asahi Kasei Corporation | om asahi kasei co jp | Asahi Medical Group - @om.asahi-kasei.co.jp | asahi research Center corp tel | Asahi Kasei Chemicals Corporation email @asahi-kasei.co.jp | asahi kasei fiber pdf | patent soluble human thrombomodulin Asahi Kasei pharma | Asahi Kasei Pharma Corporation | .

Search for more companies in New York

Search for more companies in New York

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Asahi Kasei Corporation